chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased
Clinical narrative: Tightness and pain across the chest, extreme lethargy and lack of energy.  Went from running 127 miles in an ultra marathon in March, 21 to barely being able to climb a set of stairs in October, 21.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: My wife and I tested positive for COVID-19 on December 26, 2022. I had a telehealth visit and was prescribed PAXLOVID but didn't take it. My symptoms were very mild thankfully because of the vaccine.
Age: 43.0
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: The nurse told field employee that 2 adult patients with who have the same age of 43 years old received PROQUAD instead of VARIVAX and MMR II; No additional AEs were reported; The spontaneous case was received from a nurse via company representative referring to a 43-year-old patient of unknown gender.  The patient's concurrent conditions, historical conditions, concomitant therapies, past drug reactions or allergies, and risk factors were not reported.   On an unknown date, the patient received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) instead of varicella virus vaccine live (Oka/Merck) (VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (wrong product administered). Date rep learned of the situation was confirmed to be on 16-MAR-2023 (also 16-FEB-2023, conflicting information). No further information was provided. No additional adverse events (AEs) were reported (no adverse event).  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2302USA006344:
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Accidental overdose, Incorrect dose administered, No adverse event
Clinical narrative: no additional AE; 2 doses of GARDASIL 9 in error on 2/23/2023; This spontaneous report was received from a physician and refers to a 12-year-old female patient. The patient's concurrent conditions, concomitant therapies and medical history was not provided.  On 23-FEB-2023, the patient was vaccinated with 2 doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, lot #: W009829, expiration date: 19-OCT-2024 (route of administration, and administration site were not provided) for prophylaxis in error (accidental overdose). No additional adverse events (AE) were reported (no adverse event).
Sex: U
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AEs; expired dose of RECOMBIVAX was administered; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 05-DEC-2022, the patient was vaccinated with an expired dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, pre-filled syringe, 0.5 ml, lot # U019135, expiration date: 22-NOV-2022, administered intramuscularly for prophylaxis (Expired product administered). No additional adverse event were reported (No adverse event).  This is one of several cases received from the same reporter. ; Sender's Comments:  US-009507513-2302USA008524: US-009507513-2302USA008440: US-009507513-2302USA008308: US-009507513-2302USA008328: US-009507513-2302USA008323:
Sex: U
Vaccine: VARZOS
Symptoms: Blindness, Neuropathy peripheral, Vertigo
Clinical narrative: vertigo; neuropathy; vision loss; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or around in July 2012, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster)(lot#, expiration date, dose, and route not specified).  On an unknown date, reported as shortly after receiving zoster vaccine live (ZOSTAVAX), the pt. suffered vertigo, neuropathy (Neuropathy peripheral ), and vision loss. (Blindness)  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations did not present prior to using the product. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of his condition.  As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of Company's wrongful conduct, the patient suffered serious, progressive,permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.  The outcome of the events were considered not recovered/not resolved. The events were considered related to zoster vaccine live (ZOSTAVAX).  The events were considered to be disabling by the reporter.  Upon internal review blindness and neuropathy peripheral was considered to be medically significant.
Sex: M
Vaccine: PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; expired lot of PNEUMOVAX 23 was administered to 69 year old patient; This spontaneous report was received from a pharmacist and refers to a 69-year-old male patient.   No information regarding patient's medical history, drug reactions or allergies and concomitant therapies was provided.  On 03-MAR-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # U022984, expiration date: 29-JAN-2023, 0.5 milliliter once (route of administration and anatomical location were not reported) for prophylaxis (expired vaccine used). No further information and no additional adverse event were provided (No adverse event).
Age: 15.0
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age, Vaccination error
Clinical narrative: Caller reports that to her knowledge no other adverse effects were experienced by this patient.; Caller reports that a 15 year old received PROQUAD in error on 16Feb2023.; This spontaneous report has been received from a registered nurse, regarding a 15-years-old patient of unknown gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 16-FEB-2023, the patient was vaccinated in error with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) subcutaneous injection as prophylaxis (lot number: W024549, which was determined to be valid, with an expiration date on 31-JAN-2024) (strength, dose, scheme, route of administration was not reported) (Product administered to patient of inappropriate age).   Caller reports that to her knowledge no other adverse effects were experienced by this patient and inquired if this could be counted as a valid dose in MMR &/or Varicella series.   This case is one of two reports from the same reporter.; Sender's Comments:  US-009507513-2303USA001739:
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE reported; Medical assistant reported that a dose of MMR II was inadvertently administered after its labeled expiry date.  The involved MMR II expired on 3/1/2023 and was administered on 3/3/2023.  The DILUENT used to reconstitute the MMR II was not expired.; This spontaneous report has been received from other health professional (medical assistant) concerning to a patient of an unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications included: sterile diluetnt (MERCK STERILE DILUENT).   On 03-MAR-2023, the patient was inadvertently administered a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) subcutaneous injection, at a dose of 0.5 milliliter (ml) (strength, and route of administration were not provided; lot  number U006596 that was verified to be valid, expiration date reported and established as01-MAR-2023) for prophylaxis, after it was labeled expiry date (expired product administered). It was reported that the diluent used to reconstitute the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not expired (strength, dose, oral route of administration was not provided; lot number W026513 that was verified to be valid, expiration date reported and established as 15-APR-2025).  No additional adverse event (AE) reported.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Feeling abnormal, Herpes zoster, Hypoaesthesia, Pain, Vaccination failure
Clinical narrative: Got two-shot regimen, have shingles/ Suspected vaccination failure; Shingles on head, face; worst Pain, agony; Numbness; Strange sensations on head, face; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included immune system disorder.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, numbness and feeling abnormal. On an unknown date, the outcome of the vaccination failure and pain were unknown and the outcome of the shingles, numbness and feeling abnormal were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain, numbness and feeling abnormal to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 27-FEB-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The patient got both old and more recent two shot regimen and still currently had shingles on head and face.  The patient had low immune system plus they say 90 out of 100 would not have shingles. It was the worst pain and agony. It had been going on 3months and still had numbness and strange sensations running through patients head and face. The reporter reported that take the shots as per as possible. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had the vaccine, still got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 27-FEB-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had the vaccine and still got shingles. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got the shot, but I still got shingles/suspected vaccination failure; got shingles twice; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 28-Feb-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the shot but he/she still got shingles twice. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got the shots and I've got flare ups/suspected vaccination failure; I've got flare ups 2 more time since; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 4 Mar 2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the shots and he/she had got flare ups 2 more time since. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Rash, Vaccination failure
Clinical narrative: Shingles even after 2 doses/Suspected vaccination failure; Rash consistent with shingles; Rash consistent with shingles; This case was reported by a physician via sales rep and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. On an unknown date, the outcome of the vaccination failure, shingles and rash were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and rash to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The patient came in with a rash consistent with shingles even through she had received 2 doses of Shingrix. The reporter did not consent to follow-up. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had them after the vacation/Suspected vaccination failure; Had them; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 28-Feb-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient had them after he/she took the vaccination. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got the vacinne, got shingles really bad/suspected vaccination failure; got shingles really bad; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the vaccine and got shingles really bad. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Scar, Vaccination failure
Clinical narrative: had the shingles shot and still got them/suspected vaccination failure; still got them; painful; have scars; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and scar. On an unknown date, the outcome of the vaccination failure, shingles, pain and scar were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, pain and scar to be related to Shingles vaccine.   Additional Information: GSK Receipt Date:01-MAR-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had the shingles shot and still got shingles.  The reporter stated that it was more painful than having a baby.  The patient had scars from it also. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Bell's palsy, Facial paralysis, Immunisation reaction
Clinical narrative: bell's palsy; facial paralysis; This case was reported by a consumer via interactive digital media and described the occurrence of bell's palsy in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, the patient experienced bell's palsy (serious criteria GSK medically significant) and facial paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the bell's palsy and facial paralysis were unknown.   The reporter considered the bell's palsy and facial paralysis to be related to Shingles vaccine.     Additional Information: GSK Receipt date:01-MAR-2023 Reporter's Comment:  This case was reported by a patient's wife via interactive digital media. The reporter reported that two months after her husband had his shingle vaccine and he had facial paralysis, bell's palsy. The doctors said it was from the vaccine no other cause. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: got shingles after.having two shingles vacc./suspected vaccination failure; shingles/got shingles after having two shingles vacc.; Pain and pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient had pain and pain and got shingles after having two shingles vaccination. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Sunburn, Vaccination failure
Clinical narrative: HAD SHINGLES,AFTER GETTING THE VACCINES FOR THE SHINGLES/suspected vaccination failure; SHINGLES ON RIGHT HAND SIDE OF CHEST, RIGHT BREAST; LIKED REAL BAD SUNBURN; VERY PAINFUL; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, sunburn and pain. On an unknown date, the outcome of the vaccination failure, shingles, sunburn and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, sunburn and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt date: 01-Mar-2023. Reporters Comment: This case was reported by a consumer via interactive digital media. Patient had shingles up on right hand side of chest and down around right breast about 6 month ago it was liked real bad sunburn, very painful. Additional Supportive Information:This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Ophthalmic herpes zoster, Vaccination failure
Clinical narrative: had the shot. Got it 3times/suspected vaccination failure; Got it 3times/ Fighting it in my eye!!; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and ophthalmic herpes zoster were unknown.   It was unknown if the reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingles vaccine.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient reported that it was one of the worse things that can happen to you and he/she had the shot and got them 3 times.  The patient stated that fighting them in his/her eye. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Herpes zoster, Insomnia, Pain, Rash
Clinical narrative: had shingles shot, got diagnosed with it/suspected vaccination failure; The excruciating pain is all over fight side of body. Can't tolerate clothes; rash was all over my right leg; pain goes deep into my knee, hip; got diagnosed with it; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In February 2023, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), pain localized, rash and arthralgia. The patient was treated with gabapentin and benadryl (nos) (Benadryl). On an unknown date, the outcome of the vaccination failure, shingles, pain localized and arthralgia were unknown and the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain localized, rash and arthralgia to be related to Shingles vaccine.     Additional Information: GSK Receipt date: 01-Mar-2023. Reporter's Comment: Patient stated that he/she had the shingles shot but got diagnosed with it 3 weeks ago.  The excruciating pain was all over fight side of his/her body.  The rash was all over right leg. The worst pain patient ever had.  Patient stated that he/she cannot tolerate regular clothes on his/her body. The only way patient can sleep at night is taking 2 Gabapentin, 1 Benadryl and putting ointment from essential oil on the areas the rash is gone where the pain goes deep into his/her knee, hip and lower back. Ointment works immediately. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Vaccination failure
Clinical narrative: had shingles shot, got diagnosed with it/suspected vaccination failure; The excruciating pain is all over fight side of body. Can't tolerate clothes; rash was all over my right leg; pain goes deep into my knee, hip; got diagnosed with it; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In February 2023, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), pain localized, rash and arthralgia. The patient was treated with gabapentin and benadryl (nos) (Benadryl). On an unknown date, the outcome of the vaccination failure, shingles, pain localized and arthralgia were unknown and the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain localized, rash and arthralgia to be related to Shingles vaccine.     Additional Information: GSK Receipt date: 01-Mar-2023. Reporter's Comment: Patient stated that he/she had the shingles shot but got diagnosed with it 3 weeks ago.  The excruciating pain was all over fight side of his/her body.  The rash was all over right leg. The worst pain patient ever had.  Patient stated that he/she cannot tolerate regular clothes on his/her body. The only way patient can sleep at night is taking 2 Gabapentin, 1 Benadryl and putting ointment from essential oil on the areas the rash is gone where the pain goes deep into his/her knee, hip and lower back. Ointment works immediately. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had rather shingle shot but they still got it/suspected vaccination failure; still got it; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The case was received form the consumer via interactive digital media. The reporter know some had rather shingles shot but they still got them. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. As per narrative information case was created as master case.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had the vaccine and had shingles/suspected vaccination failure; shingles/ Had shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the vaccine and had shingles. The patient thought that it would had been a worse case if he/she had not had the vaccine, but he/she was rough. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: after 2nd vaccine got shingles/suspected vaccination failure; shingles after 2nd, shorter bought; shingles after 1st, not bad; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and shingles. On an unknown date, the outcome of the vaccination failure, shingles and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 01-MAR-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had the shingles. The patient got vaccine and then got shingles again which was not as bad. The reporter reported that then after 2nd vaccine got a shorter bought with shingles. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Autoimmune disorder, Nervous system disorder
Clinical narrative: autoimmune disorder, is nerve related; This case was reported by a consumer via interactive digital media and described the occurrence of autoimmune disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced autoimmune disorder (serious criteria GSK medically significant). On an unknown date, the outcome of the autoimmune disorder was not recovered/not resolved.   The reporter considered the autoimmune disorder to be possibly related to Shingles vaccine.     Additional Information: GSK receipt date: 01-MAR-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The reporter reported that good luck to anyone who gets the Shingles shots. The patient now had nerve related autoimmune disorder from shingles vaccinations. Additional Supportive Information: The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had both vaccines, got shingles/Suspected vaccination failure; Shingles/Still got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 1-Mar-2023 Reporter's comment: The case was received from the patient via interactive digital media. The patient had both the vaccines and still got shingles. The patient reported that luckily he/she recognized them and went to the physician right away and got on the drugs to lessen the severity. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Had the shot, got shingles/Suspected vaccination failure; Shingles, mild case; Awful pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-MAR-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had the shingles shot and still got shingles.  The patient stated that, it was awful pain and it was a mild case. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Extra dose administered, Herpes zoster, Vaccination failure
Clinical narrative: Had the vaccine, got shingles/Suspected vaccination failure; Shingles; Had more shingles vaccination; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt date: 01-MAR-2023 Reporter's Comment:  This case was reported by a patient via interactive digital media. The patient had the vaccine and still got shingles but thank it was mild considering how bad it could have been. Since then patient had more shingles vaccination The follow-up could not be possible as no contact details were available. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The patient received more shingles vaccination which led to extra dose administered. The event extra dose administered was coded conservatively as follow up was not possible and it was unclear how many doses of shingles vaccine the patient received.  Being conservative, the GSK Receipt Date entered on the case was 01-Mar-2023 as this was the oldest date in the source document, though the Date the Author Published the Social Media 2 Mar 2023.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got shingles vaccine, then shingles/Suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date:01-MAR-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient got the Shingle vaccine and then the shingles again. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got shingles vaccine prior, virus blast out/Suspected vaccination failur; Virus lives in body, got triggered, blast out; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt date: 01-Mar-2023. Reporter's Comment: This case was reported by a consumer via interactive digital media. Patient received Shingle vaccine prior by about 2 years.  So patient think the virus lives for years in our body then it gets triggered to blast out. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had the shot, got shingles 5 years later/Suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 5 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 01-MAR-2023 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had the shingles shot and got shingles 5 years later.  The reporter stated that he/she was told get shingles shot every 5 years.  The reporter further stated that he/she did not know. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.  Being conservative, the GSK Receipt Date entered was 01-Mar-2023 as this was the oldest date in the source document as date the author published the social media was 2nd Mar 2023.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got shot, got shingles anyway/Suspected vaccination failure; Got Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 01-MAR-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The doctor told him that 51 percent who get shingles vaccine get it anyway. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. The case had been linked with US2023AMR034658 reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR034658:Same reporter